| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
Bexarotene-d4 manufacturers
- Bexarotene-D4
-
- $1680.00
-
2026-05-11
- CAS:2182068-00-2
- Purity:
- Supply Ability: 10g
|
| | Bexarotene-d4 Basic information |
| Product Name: | Bexarotene-d4 | | Synonyms: | Bexarotene-d4;LGD1069 D4;Bexarotene-d4
DISCONTINUED, offer alternates;4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl](2H?)benzoic acid | | CAS: | 2182068-00-2 | | MF: | C24H24D4O2 | | MW: | 352.503 | | EINECS: | | | Product Categories: | | | Mol File: | 2182068-00-2.mol |  |
| | Bexarotene-d4 Chemical Properties |
| solubility | DMF: 20 mg/ml; DMF:PBS (pH 7.2)(1:3): 0.25 mg/ml; DMSO: 10 mg/ml; Ethanol: 0.5 mg/ml | | form | A crystalline solid | | color | White to off-white |
| | Bexarotene-d4 Usage And Synthesis |
| Uses | Bexarotene-d4 is a deuterium labeled Bexarotene (LGD1069). Bexarotene (LGD1069) is a selective retinoid X receptors (RXR) agonist for the treatment of cutaneous T-cell lymphoma[1][2][3][4][5]. | | References | [1] Vakeva L, Ranki A, Hahtola S. Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland. Acta Derm Venereol. 2012 May;92(3):258-63. doi: 10.2340/00015555-1359. DOI:10.2340/00015555-1359
[2] Gui Y, et al. Bexarotent attenuated CCI-induced spinal neuroinflammation and neuropathic pain by targeting MKP-1. J Pain. 2019 Jan 17. pii: S1526-5900(18)30607-2. DOI:10.1016/j.jpain.2019.01.007
[3] Zhang X, Schlaak M, Fabri M, Mauch C, Kurschat P. Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene. Case Rep Dermatol. 2012 Jan;4(1):56-60. DOI:10.1159/000337433
[4] Orendas P, Kubatka P, Kajo K, Stollarova N, Kassayova M, Bojkova B, Pec M, Nosal V, Kiskova T, Zihlavnikova K, Karsnakova R. Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis. Neoplasma. 2012;59(4):469-74. DOI:10.4149/neo_2012_060
[5] Cras A, Politis B, Balitrand N, Darsin-Bettinger D, Boelle PY, Cassinat B, Toubert ME, Chomienne C. DOI:10.1158/1078-0432.CCR-11-0510 |
| | Bexarotene-d4 Preparation Products And Raw materials |
|